Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Mar 29;19(4):1030. doi: 10.3390/ijms19041030

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2018 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Lack of response of the three anaplastic thyroid cancer (ATC) cell lines to 10 µM retinoic acid (RA) treatment. (A) H/E staining (×40) and Cyclin D1 immunocytochemical staining (insets; ×40); (B) 3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide (MTT) cell proliferation assay; (C) flow cytometry. Control, without resveratrol treatment; RA-alone, 10 µM retinoic acid treatment. NS, without statistical significance (p > 0.05); the error bars, the mean ± standard deviation; , apoptosis peak; , G1 phase; , S phase; , G2 phase.

Lack of response of the three anaplastic thyroid cancer (ATC) cell lines to 10 µM retinoic acid (RA) treatment. (A) H/E staining (×40) and Cyclin D1 immunocytochemical staining (insets; ×40); (B) 3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide (MTT) cell proliferation assay; (C) flow cytometry. Control, without resveratrol treatment; RA-alone, 10 µM retinoic acid treatment. NS, without statistical significance (p > 0.05); the error bars, the mean ± standard deviation; , apoptosis peak; , G1 phase; , S phase; , G2 phase.